Table of Contents
WASHINGTON —The FTC has paused an enforcement action against pharmacy benefit managers alleging that they used an illicit rebate scheme that ended up raising insulin prices.
The agency is suing PBMs including: Optum RX, part of UnitedHealth Group; CVS Caremark, owned by CVS Health and Express Scripts, a subsidiary of Cigna.
FTC General Counsel Lucas Croslow, in an order, said the decision is due to not enough commissioners available to adjudicate the matter in an administrative court, Bloomberg reported, adding that Chairman Andrew Ferguson and Commissioner Melissa Holyoak have both recused themselves.
Last month, President Trump fired FTC Democratic Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, the only two members participating in the action.
The stay in the action is for at least 105 days.
